Probing the biochemistry of toxic metals in the bloodstream

探索血液中有毒金属的生物化学

基本信息

  • 批准号:
    RGPIN-2014-04156
  • 负责人:
  • 金额:
    $ 1.89万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2018
  • 资助国家:
    加拿大
  • 起止时间:
    2018-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Human activities, such as fossil fuel consumption and mining, emit quantities of toxic metals (arsenic, cadmium, mercury and manganese) that rival or exceed natural global emissions. These emissions are expected in increase. Coal consumption, for example, is expected to increase by 20% over the next 25 years. In addition, millions of people are exposed to toxic metals at their workplace through the inhalation/ingestion of toxic metal-containing dusts (e.g. sheet metal flame cutting, welding, etc.). Since toxic metals are absorbed from the gastrointestinal tract and/or the lungs, they will eventually enter the bloodstream. Although we accurately know the concentrations of the aforementioned toxic metals in the human bloodstream of the average population (these data are determined in regular intervals by the Centers of Disease Control and Prevention of the United States), we don't know at present what these concentrations mean. This undesirable situation must be largely attributed to our lack of understanding the fundamental chemical processes that unfold once these toxic metals enter the bloodstream, which in turn is associated with the difficulty of analyzing blood. Blood plasma, for example, contains up to 10,000 individual proteins. To gain much needed insight into the interactions of toxic metals in the bloodstream, my group has developed a unique visualization method for the analysis of plasma. Instead of analyzing the latter for the thousands of proteins, our method specifically analyzes plasma for those proteins which contain a bound metal and are therefore referred to as metalloproteins. The latter deliver sufficient amounts of dietary iron, copper and zinc to our organs where they are important building blocks for the assembly of proteins which maintain vital biochemical processes. From a toxicological point of view, the binding of dietary iron, copper and zinc to plasma proteins in the bloodstream is a critical step in their metabolism which can be adversely affected by toxic metals. In addition, a toxic metal may be inadvertently transported to an organ (where it causes toxicity) by binding to certain metalloproteins. Furthermore, the influx of a toxic metal into the bloodstream may change the concentration of certain metalloproteins over time. In order to probe all of these toxicologically highly relevant processes, we will use rabbits as a model organism. We will first conduct experiments with rabbit plasma to which a toxic metal is added. Simultaneous analysis of the plasma for metalloproteins and the added toxic metal will provide insight into the transport of the latter in the bloodstream and will contribute to establish the mechanisms which define the target organ of any given toxic metal. Next we will carry out similar experiments with rabbit whole blood. These investigations are expected to allow us to isolate novel toxic metal containing metabolites, which will be structurally characterized at the Canadian Light Source. This is important to identify metabolites which play a critical role in their toxicity. Since the methodology that we will employ can analyze plasma in 25 minutes, we will complement the aforementioned "test tube" experiments with studies using anesthesized rabbits. After the injection with a toxic metal, the analysis of plasma for the contained metalloproteins over an 8 h period will reveal changes of certain metalloprotein concentrations over time. It is expected that these studies will provide unique insight into the systemic toxicity of toxic metals. Overall, my research program will allow us to obtain fundamentally new insight into the toxicology of metals in the mammalian bloodstream, which will ultimately contribute to better inform Canadian public policy on the regulation of toxic metals.
人类活动,如化石燃料消耗和采矿,排放的有毒金属(砷、镉、汞和锰)数量相当于或超过全球自然排放量。预计这些排放量将增加。例如,煤炭消费量预计在未来25年内将增加20%。此外,数百万人在工作场所通过吸入/摄入含有毒金属的粉尘(例如金属板火焰切割、焊接等)接触有毒金属。由于有毒金属是从胃肠道和/或肺部吸收的,它们最终会进入血液。虽然我们准确地知道上述有毒金属在普通人群血液中的浓度(这些数据由美国疾病控制和预防中心定期测定),但我们目前不知道这些浓度意味着什么。这种不理想的情况在很大程度上是由于我们缺乏对这些有毒金属进入血液后所发生的基本化学过程的了解,这反过来又与分析血液的困难有关。例如,血浆含有多达10,000种蛋白质。为了深入了解血液中有毒金属的相互作用,我的团队开发了一种独特的可视化方法来分析血浆。我们的方法不是分析后者的数千种蛋白质,而是专门分析血浆中含有结合金属的蛋白质,因此被称为金属蛋白。后者向我们的器官提供足够量的膳食铁,铜和锌,它们是维持重要生化过程的蛋白质组装的重要组成部分。从毒理学的角度来看,饮食中的铁、铜和锌与血液中的血浆蛋白结合是其代谢的关键步骤,有毒金属可能会对其产生不利影响。此外,有毒金属可能通过与某些金属蛋白结合而无意中转运到器官(在那里它引起毒性)。此外,有毒金属流入血液可能会随着时间的推移改变某些金属蛋白的浓度。为了探索所有这些毒理学高度相关的过程,我们将使用家兔作为模型生物。我们将首先用添加了有毒金属的兔子血浆进行实验。同时分析血浆中的金属蛋白和添加的有毒金属将提供对后者在血流中的运输的了解,并将有助于建立定义任何给定的有毒金属的靶器官的机制。接下来,我们将用家兔全血进行类似的实验。这些研究预计将使我们能够分离出新的含有毒金属的代谢物,这些代谢物将在加拿大光源进行结构表征。这对于鉴定在其毒性中起关键作用的代谢物是重要的。由于我们将采用的方法可以在25分钟内分析血浆,因此我们将使用麻醉家兔进行研究,以补充上述“试管”实验。注射有毒金属后,在8小时内分析血浆中所含的金属蛋白将揭示某些金属蛋白浓度随时间的变化。预计这些研究将为有毒金属的全身毒性提供独特的见解。总的来说,我的研究计划将使我们能够从根本上了解哺乳动物血液中金属的毒理学,这将最终有助于更好地了解加拿大关于有毒金属监管的公共政策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gailer, Juergen其他文献

Structural characterization of Cd2+ complexes in solution with DMSA and DMPS
  • DOI:
    10.1016/j.jinorgbio.2013.10.025
  • 发表时间:
    2014-07-01
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Jahromi, Elham Zeini;Gailer, Juergen;George, Graham N.
  • 通讯作者:
    George, Graham N.
Physiologically relevant hCys concentrations mobilize MeHg from rabbit serum albumin to form MeHg-hCys complexes
  • DOI:
    10.1093/mtomcs/mfac010
  • 发表时间:
    2022-03-21
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Bridle, Tristen G.;Doroudian, Maryam;Gailer, Juergen
  • 通讯作者:
    Gailer, Juergen
Reversed-phase high-performance liquid chromatographic separation of inorganic mercury and methylmercury driven by their different coordination chemistry towards thiols
  • DOI:
    10.1016/j.chroma.2006.12.061
  • 发表时间:
    2007-07-13
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Percy, Andrew J.;Korbas, Malgorzata;Gailer, Juergen
  • 通讯作者:
    Gailer, Juergen
Hg2+ and Cd2+ interact differently with biomimetic erythrocyte membranes
  • DOI:
    10.1007/s10534-008-9162-7
  • 发表时间:
    2009-04-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Le, Mary Trang;Gailer, Juergen;Prenner, Elmar J.
  • 通讯作者:
    Prenner, Elmar J.
Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma
  • DOI:
    10.1039/c3mt00238a
  • 发表时间:
    2014-01-01
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Sooriyaarachchi, Melani;White, Wade M.;Gailer, Juergen
  • 通讯作者:
    Gailer, Juergen

Gailer, Juergen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gailer, Juergen', 18)}}的其他基金

Probing bioinorganic chemistry processes in the bloodstream
探索血液中的生物无机化学过程
  • 批准号:
    RGPIN-2019-04376
  • 财政年份:
    2022
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing bioinorganic chemistry processes in the bloodstream
探索血液中的生物无机化学过程
  • 批准号:
    RGPIN-2019-04376
  • 财政年份:
    2021
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing bioinorganic chemistry processes in the bloodstream
探索血液中的生物无机化学过程
  • 批准号:
    RGPIN-2019-04376
  • 财政年份:
    2020
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing bioinorganic chemistry processes in the bloodstream
探索血液中的生物无机化学过程
  • 批准号:
    RGPIN-2019-04376
  • 财政年份:
    2019
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Visit of Lumex Instruments Canada
加拿大Lumex Instruments来访
  • 批准号:
    531293-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Connect Grants Level 1
Development of an application to quantify clinically relevant metalloproteins in human blood plasma********
开发量化人血浆中临床相关金属蛋白的应用********
  • 批准号:
    537264-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Engage Grants Program
Probing the biochemistry of toxic metals in the bloodstream
探索血液中有毒金属的生物化学
  • 批准号:
    RGPIN-2014-04156
  • 财政年份:
    2017
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing the biochemistry of toxic metals in the bloodstream
探索血液中有毒金属的生物化学
  • 批准号:
    RGPIN-2014-04156
  • 财政年份:
    2016
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing the biochemistry of toxic metals in the bloodstream
探索血液中有毒金属的生物化学
  • 批准号:
    RGPIN-2014-04156
  • 财政年份:
    2015
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual
Probing the biochemistry of toxic metals in the bloodstream
探索血液中有毒金属的生物化学
  • 批准号:
    RGPIN-2014-04156
  • 财政年份:
    2014
  • 资助金额:
    $ 1.89万
  • 项目类别:
    Discovery Grants Program - Individual

相似海外基金

Environmental Chemical Impact on the Host-Microbiome Interaction
环境化学对宿主-微生物组相互作用的影响
  • 批准号:
    10641509
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Division of Chemical Toxicology Symposia at the 266th National ACS Meeting
第266届全国ACS会议化学毒理学研讨会分部
  • 批准号:
    10753870
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
  • 批准号:
    10732666
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Bacterial metabolism of catechol-O-methyltransferase inhibitors alters drug efficacy and toxicity
儿茶酚-O-甲基转移酶抑制剂的细菌代谢改变药物疗效和毒性
  • 批准号:
    10606184
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)
开发可食用吸附剂疗法以减少膳食中全氟烷基物质和多氟烷基物质 (PFAS) 的暴露
  • 批准号:
    10590799
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Anti-HIV and anti-reactivation activities of pyrrolopyridine-based ALLINIs
基于吡咯并吡啶的 ALLINI 的抗 HIV 和抗再激活活性
  • 批准号:
    10762564
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Development of a new class of BLVRB-targeted redox therapeutics in breast cancer
开发一类新型 BLVRB 靶向乳腺癌氧化还原疗法
  • 批准号:
    10759653
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Investigation of Long-Range Charge Transfer and Excited State Processes in Biochemical Systems
生化系统中长程电荷转移和激发态过程的研究
  • 批准号:
    10713085
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
Anti-medin immunotherapy for vascular aging and related dementias
针对血管老化和相关痴呆的抗 Medin 免疫疗法
  • 批准号:
    10724869
  • 财政年份:
    2023
  • 资助金额:
    $ 1.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了